A preliminary study suggests that CTA can play the role cardiac MRI has been playing for detecting and quantifying myocardial infarction to estimate the potential success of coronary bypass graft surgery.
A preliminary study suggests that CTA can play the role cardiac MRI has been playing for detecting and quantifying myocardial infarction to estimate the potential success of coronary bypass graft surgery.
Establishing the feasibility of perfusion CT to do what cardiac MRA does for delayed-enhancement myocardial imaging could eliminate the need for cardiac MRA in this important function and help speed therapy decision-making for surgical candidates.
Dr. Yoon Jin Lee and colleagues working in Seoul, Korea, were encouraged by the results of 10-minute delayed-enhancement, ECG-gated examinations performed with dual-source CT and cardiac MR for 29 patients requiring pre-coronary artery bypass graft surgery workups.
Delayed-enhancement and infarction volumes over total myocardial volume were evaluated by two radiologists using a 19-segment model for dual-source CT and cardiac MR. Ventricular function measures were also acquired using both techniques. The myocardium was considered viable when delayed enhancement failed to reveal any transmural deficit of greater than 50%.
Delayed enhancement was observed in 17 patients with both cardiac MR and dual-source CT. Cardiac MR caught a delayed-enhancement void in one patient that was not seen with dual-source CT.
Lee noted that the percentage of infarction volume was not significantly different between the two modalities, though the correlation was strongest for patients with ventricular ejection fractions greater than 40%.
The sensitivity and specificity of dual-source CT for detecting transmural infarctions greater than 50% were 95% and 77% respectively.
Though larger multicenter randomized trials are needed to validate the findings, Lee’s work strongly suggests that perfusion CT will eventually challenge cardiac MR for this application.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.